Literature DB >> 10658539

Biological monitoring of occupational exposure to inorganic arsenic.

P Apostoli1, D Bartoli, L Alessio, J P Buchet.   

Abstract

OBJECTIVES: This study was undertaken to assess reliable biological indicators for monitoring the occupational exposure to inorganic arsenic (iAs), taking into account the possible confounding role of arsenicals present in food and of the element present in drinking water.
METHODS: 51 Glass workers exposed to As trioxide were monitored by measuring dust in the breathing zone, with personal air samplers. Urine samples at the end of work shift were analysed for biological monitoring. A control group of 39 subjects not exposed to As, and eight volunteers who drank water containing about 45 micrograms/l iAs for a week were also considered. Plasma mass spectrometry (ICP-MS) was used for the analysis of total As in air and urine samples, whereas the urinary As species (trivalent, As3; pentavalent, As5; monomethyl arsonic acid, MMA; dimethyl arsinic acid, DMA; arsenobetaine, AsB) were measured by liquid chromatography coupled with plasma mass spectrometry (HPLC-MS)
RESULTS: Environmental concentrations of As in air varied widely (mean 84 micrograms/m3, SD 61, median 40) and also the sum of urinary iAs MMA and DMA, varied among the groups of exposed subjects (mean 106 micrograms/l, SD 84, median 65). AsB was the most excreted species (34% of total As) followed by DMA (28%), MMA (26%), and As3 + As5 (12%). In the volunteers who drank As in the water the excretion of MMA and DMA increased (from a median of 0.5 to 5 micrograms/day for MMA and from 4 to 13 micrograms/day for DMA). The best correlations between As in air and its urinary species were found for total iAs and As3 + As5.
CONCLUSIONS: To avoid the effect of As from sources other than occupation on urinary species of the element, in particular on DMA, it is proposed that urinary As3 + As5 may an indicator for monitoring the exposure to iAs. For concentrations of 10 micrograms/m3 the current environmental limit for iAs, the limit for urinary As3 + As5 was calculated to be around 5 micrograms/l, even if the wide variation of values needs critical evaluation and application of data. The choice of this indicator might be relevant also from a toxicological point of view. Trivalent arsenic is in fact the most active species and its measure in urine could be the best indicator of some critical effects of the element, such as cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10658539      PMCID: PMC1757692          DOI: 10.1136/oem.56.12.825

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  46 in total

1.  Exposure to arsenic and respiratory cancer. A reanalysis.

Authors:  P E Enterline; V L Henderson; G M Marsh
Journal:  Am J Epidemiol       Date:  1987-06       Impact factor: 4.897

2.  Excretion of a single oral dose of fish-arsenic in man.

Authors:  G K Tam; S M Charbonneau; F Bryce; E Sandi
Journal:  Bull Environ Contam Toxicol       Date:  1982-06       Impact factor: 2.151

3.  Human retention studies with 74As.

Authors:  C Pomroy; S M Charbonneau; R S McCullough; G K Tam
Journal:  Toxicol Appl Pharmacol       Date:  1980-05       Impact factor: 4.219

4.  Biological monitoring of arsenic exposure of gallium arsenide- and inorganic arsenic-exposed workers by determination of inorganic arsenic and its metabolites in urine and hair.

Authors:  H Yamauchi; K Takahashi; M Mashiko; Y Yamamura
Journal:  Am Ind Hyg Assoc J       Date:  1989-11

5.  Relation between airborne arsenic trioxide and urinary excretion of inorganic arsenic and its methylated metabolites.

Authors:  J A Offergelt; H Roels; J P Buchet; M Boeckx; R Lauwerys
Journal:  Br J Ind Med       Date:  1992-06

6.  Metabolism of arsenobetaine in mice, rats and rabbits.

Authors:  M Vahter; E Marafante; L Dencker
Journal:  Sci Total Environ       Date:  1983-09       Impact factor: 7.963

7.  Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic.

Authors:  C Hopenhayn-Rich; A H Smith; H M Goeden
Journal:  Environ Res       Date:  1993-02       Impact factor: 6.498

8.  The metabolism of arsenic in humans acutely intoxicated by As2O3. Its significance for the duration of BAL therapy.

Authors:  P Mahieu; J P Buchet; H A Roels; R Lauwerys
Journal:  Clin Toxicol       Date:  1981-09       Impact factor: 4.467

9.  Role of thiols in the in-vitro methylation of inorganic arsenic by rat liver cytosol.

Authors:  J P Buchet; R Lauwerys
Journal:  Biochem Pharmacol       Date:  1988-08-15       Impact factor: 5.858

10.  Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observations in man.

Authors:  J P Buchet; R Lauwerys
Journal:  Arch Toxicol       Date:  1985-06       Impact factor: 5.153

View more
  10 in total

1.  Seafood intake and urine concentrations of total arsenic, dimethylarsinate and arsenobetaine in the US population.

Authors:  Ana Navas-Acien; Kevin A Francesconi; Ellen K Silbergeld; Eliseo Guallar
Journal:  Environ Res       Date:  2010-11-19       Impact factor: 6.498

2.  Arsenic speciation analysis of urine samples from individuals living in an arsenic-contaminated area in Bangladesh.

Authors:  Akihisa Hata; Kenzo Yamanaka; Mohamed Ahsan Habib; Yoko Endo; Noboru Fujitani; Ginji Endo
Journal:  Environ Health Prev Med       Date:  2011-11-03       Impact factor: 3.674

3.  Arsenic exposure in the wine growing industry in ten French departments.

Authors:  J P Grillet; A Adjémian; G Bernadac; J Bernon; F Brunner; R Garnier
Journal:  Int Arch Occup Environ Health       Date:  2003-12-12       Impact factor: 3.015

4.  Immunotoxicity and biodistribution analysis of arsenic trioxide in C57Bl/6 mice following a 2-week inhalation exposure.

Authors:  Scott W Burchiel; Leah A Mitchell; Fredine T Lauer; Xi Sun; Jacob D McDonald; Laurie G Hudson; Ke Jian Liu
Journal:  Toxicol Appl Pharmacol       Date:  2009-10-02       Impact factor: 4.219

5.  μLC-ICP-MS determinations of unexposed UK urinary arsenic speciation reference values.

Authors:  Elizabeth Leese; Jackie Morton; Emma Tan; Philip H E Gardiner; Vikki A Carolan
Journal:  J Anal Toxicol       Date:  2013-11-01       Impact factor: 3.367

6.  A biological indicator of inorganic arsenic exposure using the sum of urinary inorganic arsenic and monomethylarsonic acid concentrations.

Authors:  Akihisa Hata; Hidetoshi Kurosawa; Yoko Endo; Kenzo Yamanaka; Noboru Fujitani; Ginji Endo
Journal:  J Occup Health       Date:  2016-03-24       Impact factor: 2.708

Review 7.  In vivo and in vitro methods for evaluating soil arsenic bioavailability: relevant to human health risk assessment.

Authors:  Karen D Bradham; Gary L Diamond; Michele Burgess; Albert Juhasz; Julie M Klotzbach; Mark Maddaloni; Clay Nelson; Kirk Scheckel; Sophia M Serda; Marc Stifelman; David J Thomas
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2018       Impact factor: 8.071

8.  Biological monitoring and the influence of genetic polymorphism of As3MT and GSTs on distribution of urinary arsenic species in occupational exposure workers.

Authors:  Beata Janasik; Edyta Reszka; Magdalena Stanislawska; Edyta Wieczorek; Wojciech Fendler; Wojciech Wasowicz
Journal:  Int Arch Occup Environ Health       Date:  2014-12-10       Impact factor: 3.015

9.  Assessment of museum staff exposure to arsenic while handling contaminated exhibits by urinalysis of arsenic species.

Authors:  Amanda Mithander; Thomas Göen; Gitte Felding; Peter Jacobsen
Journal:  J Occup Med Toxicol       Date:  2017-08-25       Impact factor: 2.646

10.  Biological monitoring of exposure to polycyclic aromatic hydrocarbons and to metallic elements in Italian Navy workers operating near the industrial area in Taranto (South Italy).

Authors:  Piero Lovreglio; Mauro Barbierato; Filippo Crociata; Enrico Tomao; Laura Diomede; Elisabetta Gallo; Pietro Scaramuzzo; Ignazio Drago; Matteo Paganelli; Pietro Apostoli; Leonardo Soleo
Journal:  Med Lav       Date:  2018-10-30       Impact factor: 1.275

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.